Hinge Health HNGE
United StatesHealthcare · Health Information ServicesUSD
110.56 USD (+13.0%)
16 analysts
Trading 2120.30 €Open account ↗
Lightyear0.90 €Open account ↗
N260.90 €Open account ↗
XTB1.00 €★ featured · affiliateOpen account ↗Trading 2120.30 €Open account ↗Lightyear0.90 €Open account ↗XTB1.00 €★ featured · affiliateOpen account ↗200.00 € order · cheapest cheapest available in your country iCompare all 22 brokers →What does it do?
Hinge Health is a digital health company offering sensor-based musculoskeletal therapy programs and virtual care, sold primarily to employers and insurers.
Key points
from its scores- ✓Strong growth10.0
- ✓Good share-price trend9.8
- ✓High-quality business9.5
- ✕Little or no dividend1.5
- ✕Demanding valuation3.1
AI analysis
bottom line, main risk, context and newsStrong growth and business quality justify the premium, but the current valuation leaves little room for error.
Hinge Health shows solid financial health with net cash (ND/EBITDA -4.01), high profitability (ROIC 38.8%), and 53% revenue growth, though its demanding valuation (P/E 32.3, EV/EBITDA 78.5) limits the margin of safety.
The demanding valuation (EV/EBITDA 78.5) depends on sustaining 53% growth; any slowdown in adoption of its programs could compress the multiple.
Context and risks
No recent news and no material exposure to current macro factors (rates, energy, tariffs). The digital health business with net cash is unaffected by the rate rise or geopolitics.
Is Hinge Health stock cheap or expensive?
at the analysis dateOn P/E and EV / EBITDA, it trades 232% above the Healthcare median on average.
| Multiple | Company | Sector | Difference |
|---|---|---|---|
| P/E | 32.3 | 26.7 | +21% |
| EV / EBITDA | 78.5 | 14.5 | +443% |
| Price / book | 22.8 | 4.1 | +455% |
| Price / sales | 11.0 | 3.4 | +221% |
Sector: median of the 217 Healthcare companies analysed. In bold, the multiples used for the comparison.
Valuation score: 3.1 out of 10 (median for Healthcare: 4.7).
Average analyst target: 110.56 USD, +13.0% versus the price.
A premium can be justified if the company is of higher quality or grows faster than its sector: Quality / Moat 9.5 (sector 5.5), Growth 10.0 (sector 6.6).
Classic formulas with standard assumptions (0.9% growth, 8-9% discount rate). Indicative only: they change a lot with the assumptions and are not a recommendation.
Work out its fair value yourself →How much would you have made investing every month? →
Comparing it with its sector does not say whether it is a good buy: this is not investment advice.
Score by category
0 to 10 · hover overtap each one to see what it measuresKey metrics
at the analysis date · compared with the Healthcare medianValuation
- P/E
- 32.3
- Forward P/E
- 32.0
- EV / EBITDA
- 78.5
- Price / book
- 22.8
- Price / sales
- 11.0
- Market cap
- 7.9B USD
- Enterprise value
- 7.5B USD
Profitability
- ROE
- 30.4%
- ROA
- 7.7%
- ROIC (approx.)
- 38.8%
- Gross margin
- 84.5%
- Operating margin
- 19.0%
- Net margin
- 15.1%
- Free cash flow
- 299.6M USD
- FCF yield
- 3.8%
- Cash conversion
- 313%
Solvency
- Total debt
- 5.9M USD
- Net debt
- −383.5M USD
- Cash
- 389.4M USD
- EBITDA
- 95.7M USD
- Net debt / EBITDA
- −4.01
- Debt / equity
- 1.71
- Current ratio
- 1.34
- Quick ratio
- 1.07
Growth
- Revenue growth
- +53.0%
- EPS (TTM)
- 3.03 USD
- EPS (forward)
- 3.06 USD
Dividend
- Dividend yield
- 0.0%
- Payout
- 0.0%
Risk and market
- Analyst consensus
- Buy (16)
- Target price
- 110.56 USD
- 52-week range
- 30.08 – 100.36
Recent news
All HNGE news →Compare it with its sector
All 217 in Healthcare →Frequently asked questions about Hinge Health
Is Hinge Health stock cheap or expensive?
On P/E and EV / EBITDA, it trades 232% above the Healthcare median on average. Valuation score: 3.1 out of 10 (median for Healthcare: 4.7). Average analyst target: 110.56 USD, +13.0% versus the price. This is not investment advice.
What score does Hinge Health get on MeridIAn Screener?
It scores 6.5 out of 10, rank 539 of 2,130 (better than 72% of the companies analysed). Its strongest category is Growth (10.0) and its weakest, Dividend (1.5). Analysis of 08/10/2026.
What is Hinge Health's P/E ratio?
Its P/E is 32.3: the share price equals 32.3 times earnings per share over the last 12 months. The Healthcare median is 26.7. Based on the earnings analysts expect, the forward P/E is 32.0.
How much is Hinge Health worth on the stock market?
Its market capitalisation is 7.9B USD and its enterprise value, debt included, is 7.5B USD.
How much debt does Hinge Health have?
It has more cash than debt: net cash of 383.5M USD.
Does Hinge Health pay a dividend?
It pays no dividend, or almost none.
How has Hinge Health stock performed over the last year?
It has risen 96.5% over the last year, excluding dividends. Over the last 52 weeks it has traded between 30.08 and 100.36 USD. Past performance does not guarantee future results.
What do analysts think of Hinge Health?
16 analysts cover it; their average recommendation is “Buy” and their average target is 110.56 USD (+13.0% versus the price). It is an estimate, not market data.